Researchers Sheryl Winston Smith, PhD, and Andrew Sfekas, PhD, analyzed premarket approvals for Medtronic, Johnson & Johnson, Boston Scientific and Guidant, as well as patent applications of 118 start ups that received investments from the four incumbent device makers, according to the report.
Results showed physician-founded companies provided 11 percent of the information in PMAs versus 4 percent from non physician-founded companies. The four major companies were much more likely to use physician-founded company patents in their devices. Thus, restricting financial relationships between providers and device manufacturers could hurt innovation, the researchers concluded.
More Articles on Devices:
NuVasive Gross Profits Up 4.9% in Q1
20 News Updates for Orthopedic & Spine Device Companies
Alphatec Spine Gross Profits Increase 2.9% in Q1
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
